Filing Details

Accession Number:
0001125345-17-000044
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-20 16:15:19
Reporting Period:
2017-04-19
Filing Date:
2017-04-20
Accepted Time:
2017-04-20 16:15:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587487 Marc Jon Wigginton 9704 Medical Center Drive
Rockville MD 20850
Sr Vp, Clinical Dev. & Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-04-19 15,000 $4.70 45,000 No 4 M Direct
Common Stock Disposition 2017-04-19 15,000 $20.00 30,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee stock option (right to buy) Disposition 2017-04-19 15,000 $0.00 15,000 $4.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,448 2014-01-18 2023-07-18 No 4 M Direct
Footnotes
  1. The sales reported in this form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on December 15, 2016.
  2. This transaction was executed in multiple trades at prices ranging from $20 to $20.03.
  3. This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which vest on 2/25/18.